| Target Price | $2.30 |
| Price | $0.31 |
| Potential |
645.86%
register free of charge
|
| Number of Estimates | 8 |
|
8 Analysts have issued a price target aTyr Pharma, Inc. 2027 .
The average aTyr Pharma, Inc. target price is $2.30.
This is
645.86%
register free of charge
$7.35
2,288.69%
register free of charge
$1.01
228.24%
register free of charge
|
|
| A rating was issued by 15 analysts: 9 Analysts recommend aTyr Pharma, Inc. to buy, 6 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the aTyr Pharma, Inc. stock has an average upside potential 2027 of
645.86%
register free of charge
|
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Freedom Broker |
Locked
➜
Locked
|
Locked | May 20 2026 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Nov 07 2025 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Sep 16 2025 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Sep 16 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 15 2025 |
| Jefferies |
Locked
➜
Locked
|
Locked | Aug 22 2025 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Jun 20 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Freedom Broker:
Locked
➜
Locked
|
May 20 2026 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Nov 07 2025 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Sep 16 2025 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Sep 16 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 15 2025 |
|
Locked
Jefferies:
Locked
➜
Locked
|
Aug 22 2025 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Jun 20 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


